Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Sagara M, Suzuki K, Aoki C, Tanaka S, Taguchi I, Inoue T, et al
Our nutrition tools support real-world routines, not rigid rules
Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism
However, some agents [including glucagon-like peptide (GLP)-1 receptor agonists and SGLT2 inhibitors] have already demonstrated benefits in populations without diabetes, and it is these agents, along with metformin, that hold out the most promise for further investigation in sarcopenia
Hoaglin DC, Hawkins N, Jansen JP, Scott DA, Itzler R, Cappelleri JC, et al
US$ 20.63
US$ 27.93
US$ 23.24
